Telehealth Anxiety Prescribing: What Psychiatrists Can Do in Michigan

You’re a psychiatrist or PMHNP evaluating telehealth opportunities, and you need straight answers: Can I prescribe anxiety medications remotely? What about controlled substances like benzodiazepines? Do the rules differ by state?

The short answer: Yes, psychiatrists can prescribe anxiety medications—including controlled substances—via telehealth in 2026. Federal flexibilities extended through December 2026 allow you to initiate and manage benzodiazepines, SSRIs, and other anxiolytics entirely through virtual visits, without requiring an initial in-person exam. But state-specific rules, PMHNP authority differences, and evolving DEA regulations create nuances you need to understand.

This guide breaks down exactly what you can do, state-by-state prescribing authority, how PMHNP rules differ from MDs, reimbursement realities, and what platforms like Klarity Health offer providers managing anxiety patients remotely.

Federal Telehealth Prescribing Rules: Where We Stand in 2026

The Ryan Haight Act Waiver Continues

Historically, the Ryan Haight Act required at least one in-person medical evaluation before prescribing controlled substances. COVID-19 emergency declarations suspended this requirement in March 2020, and that flexibility has been repeatedly extended.

As of February 2026, you can still prescribe Schedule II-V controlled substances via telehealth without any prior in-person visit. The DEA and HHS extended these flexibilities through December 31, 2026, preventing a ‘telemedicine cliff’ that would have cut off millions of patients from their medications.

In 2024 alone, over 7 million controlled substance prescriptions for ADHD, anxiety, and other conditions were written via telemedicine without in-person encounters. The extension gives regulators time to finalize permanent telehealth prescribing rules expected later in 2026.

What this means for anxiety treatment:

• You can conduct initial psychiatric evaluations via video
• Prescribe SSRIs, SNRIs, buspirone, beta-blockers without restriction
• Initiate benzodiazepines (alprazolam, clonazepam, lorazepam—Schedule IV) for appropriate anxiety cases
• Manage ongoing medication adjustments and refills entirely remotely
• Prescribe across state lines if you hold an active license in the patient’s state

What you should watch: The DEA is developing permanent telemedicine regulations. These may introduce a special telemedicine prescribing registration or reinstate modified exam requirements. Stay alert for final rules expected Q4 2026, but for now, you have full telehealth prescribing authority through year-end.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State-Specific Telehealth Prescribing Rules for Anxiety Medications

While federal policy permits broad telehealth prescribing, individual states can impose additional restrictions. Here’s what matters in key markets:

Florida: Psychiatric Exemption for Schedule II

Florida generally prohibits telehealth prescribing of Schedule II controlled substances—but carved out an explicit exception for psychiatric disorders. This means:

• You can prescribe Schedule II stimulants via telehealth for comorbid ADHD/anxiety (if clinically appropriate)
• Benzodiazepines (Schedule IV) have no telehealth restriction whatsoever
• You must check Florida’s PDMP (E-FORCSE) before prescribing any controlled substance
• Out-of-state providers: Florida offers a telehealth provider registration, but those with only this registration (not a full FL license) cannot prescribe controlled substances remotely

If you’re fully licensed in Florida, you operate under standard-of-care guidelines with no special telehealth limitations for anxiety treatment.

Texas: Anxiety Treatment Permitted, Pain Management Prohibited

Texas law explicitly bans telemedicine treatment of chronic pain with controlled substances—but anxiety treatment doesn’t fall under this restriction.

What you can do:

• Establish a patient-provider relationship via live audio-visual exam
• Prescribe benzodiazepines and other Schedule IV anxiolytics remotely
• Manage anxiety medication indefinitely via telehealth

What you should know:

• No telehealth payment parity law (insurers aren’t required to pay equally for virtual visits, though many do)
• Mandatory Texas PMP check before prescribing controlled substances
• Texas participates in the Interstate Medical Licensure Compact (IMLC) for easier multi-state licensing

California: No Telehealth Prescribing Restrictions

California imposes no unique barriers beyond federal requirements. You can:

• Conduct initial psychiatric evaluations via video
• Prescribe all anxiety medications including controlled substances
• Bill at equal rates for telehealth (AB 744 payment parity law)

California does not participate in IMLC, so out-of-state psychiatrists must obtain a full California license to treat CA patients remotely.

New York: Full Telehealth Parity

New York integrates telehealth into standard practice with no special prescribing limitations. Key points:

• No differentiation between telehealth and in-person for prescribing authority
• Mandatory iSTOP PDMP check for every controlled substance prescription
• Insurance parity for tele-mental health services
• Medicare consideration: Federal rules may eventually require periodic in-person visits for Medicare tele-mental health (enforcement delayed through 2024-2025; verify current status)

Pennsylvania: Follow Federal Rules

Pennsylvania has no comprehensive state telehealth statute but allows telemedicine prescribing under professional board guidance. Providers follow federal controlled substance rules and standard-of-care documentation. Many insurers voluntarily reimburse telepsychiatry at parity.

Illinois: Strong Telehealth Support

Illinois enacted insurance parity laws in 2021, requiring equal coverage and reimbursement for telehealth mental health services. No state barriers to prescribing via telehealth; providers must check Illinois PMP before initiating controlled substances.

PMHNP vs Psychiatrist Prescribing Authority: Critical Differences

While psychiatrists enjoy unrestricted prescribing authority nationwide, PMHNPs face state-dependent limitations that significantly impact anxiety treatment.

Full Practice Authority States

About half of U.S. states grant PMHNPs Full Practice Authority (FPA), allowing independent evaluation, diagnosis, and prescribing without physician supervision.

New York (FPA since 2022):

• PMHNPs practice completely independently—no written agreements, no mandatory collaboration
• Can prescribe all anxiety medications including controlled substances
• Authority essentially equivalent to psychiatrists for anxiety treatment

Other FPA states include: Oregon, Washington, Arizona, Maryland, New Mexico

In these states, a PMHNP’s scope for managing anxiety is clinically identical to a psychiatrist’s, though Medicare reimburses NPs at 85% of physician rates.

Reduced/Restricted Practice States

States requiring physician collaboration or supervision create practical barriers for PMHNPs treating anxiety.

California (Transitioning to Independence):

• Historically restricted (required standardized physician procedures)
• AB 890 (2020) created pathway to independence:
• 103 NP status (available since Jan 2023): Practice without physician procedures in group settings with at least one physician in the organization
• 104 NP status (available Jan 2026): Full independent practice after 3 years as 103 NP
• Until achieving 104 status, PMHNPs need physician agreements for prescribing

Texas (Highly Restrictive):

• Mandatory Prescriptive Authority Agreement with Texas physician
• Cannot prescribe Schedule II controlled substances outside hospital/hospice settings (limits stimulant prescribing for comorbid ADHD)
• Benzodiazepines (Schedule IV) can be prescribed if authorized in delegation agreement
• Physician must supervise with periodic chart reviews
• No pathway to independence—this applies throughout entire NP career in Texas

Florida (Restricted with Nuances):

• PMHNPs require supervising psychiatrist/physician with written protocol
• Special rule for psychiatric NPs: Can prescribe controlled substances beyond the standard 7-day limit when treating mental disorders
• Allows more than 7 days of benzodiazepines if Board-certified PMHNP treating anxiety disorder
• Cannot prescribe Schedule II stimulants for more than 7 days (unless psychiatric NP treating ADHD/similar condition)

Pennsylvania (Collaborative Agreement Required):

• Mandatory collaboration agreement throughout career
• Physician must countersign percentage of charts (100% for Schedule II within 24 hours)
• Agreement specifies which medication categories NP can prescribe
• If collaborating psychiatrist isn’t comfortable with NP prescribing benzodiazepines, the agreement may prohibit it

Illinois (Pathway to Independence):

• New NPs require collaboration agreement
• After 4,000 clinical hours + 250 CE hours, can apply for Full Practice Authority
• Even with FPA, need physician attestation for prescribing benzodiazepines/Schedule II (one-time acknowledgment, then can prescribe independently)
• Requires separate Illinois controlled substance license plus DEA registration

The Bottom Line for PMHNPs

Your ability to independently prescribe anxiety medications—particularly benzodiazepines—depends entirely on your state. In FPA states, you practice with authority equivalent to psychiatrists. In restricted states, you must:

1. Find and maintain a physician collaborator (potentially costly—some charge collaboration fees)
2. Operate within the scope defined in your agreement
3. Navigate geographic restrictions (e.g., Texas 75-mile proximity requirements)
4. Accept that your telehealth practice may require a local physician partner

This is why platforms like Klarity structure their provider networks carefully—either pairing NPs with physician collaborators where required or focusing recruitment in states with favorable NP practice laws.

Medication Management Reimbursement: What You’ll Actually Earn

Understanding reimbursement helps you evaluate telehealth opportunities realistically.

Medicare Rates (2026 Benchmark)

Medicare pays psychiatrists generously for medication management relative to other specialties:

Telehealth parity: Through at least September 2025 (likely extended into 2026), Medicare pays telehealth visits at the same rate as in-person for mental health services.

Medicare caveat: There was a proposed requirement for periodic in-person visits for tele-mental health (every 6 months initially, then annually). Congress has delayed enforcement; verify current policy, but through 2024-2025 you can treat Medicare anxiety patients entirely via telehealth.

Medicaid Rates (Significantly Lower)

Medicaid pays roughly 50-60% of Medicare rates:

• 90792 initial eval: ~$85 (vs $202 Medicare)
• 99213 med check: ~$40-50 (vs $95 Medicare)
• 99214 complex visit: ~$65-75 (vs $136 Medicare)

Most states now cover tele-mental health at equal rates to in-person and allow treatment from patient’s home. High patient volume can offset lower per-visit pay.

Commercial Insurance

Private insurers typically pay 100-150% of Medicare rates:

• 99213 med check: $80-$130
• 99214 complex visit: $120-$180
• 90792 initial eval: $150-$250

Many states have telehealth parity laws requiring equal reimbursement for virtual visits (California AB 744, Illinois, New York). Texas has no mandated parity, but many insurers pay equivalently for tele-mental health.

PMHNP Reimbursement Difference

When a PMHNP bills under their own NPI:

• Medicare pays 85% of the physician fee schedule
• Example: If psychiatrist receives $100 for a visit, PMHNP receives $85
• Some states’ Medicaid pays NPs equally; others discount 10-15%
• Private insurers vary but often pay NPs at reduced rates

‘Incident to’ billing (where NP services bill under physician NPI at 100% rate) generally doesn’t work in psychiatry or telehealth due to strict supervision requirements.

For telehealth platforms: This 15% Medicare differential factors into provider compensation models. Platforms may pay NPs slightly less per visit than psychiatrists, though NP salaries are also typically lower, creating economic balance.

Economic Reality for Providers

A psychiatrist doing anxiety medication management via telehealth might see:

• 4 patients/hour (15-minute med checks)
• $95 × 4 = $380/hour gross revenue (Medicare rates)
• Platform takes service fee (varies—20-40% typical)
• Provider net: $228-$304/hour depending on arrangement

Compare to building your own practice:

• Marketing costs: $200-500+ per acquired patient (SEO, Google Ads, directories)
• SEO investment: 6-12 months before meaningful patient flow
• Google Ads: $15-40+ per click, realistic $200-400+ cost per booked patient
• Psychology Today/Zocdoc: Monthly fees + per-booking charges
• No guarantees—you’re gambling on marketing channels vs guaranteed ROI

Platforms like Klarity use a pay-per-appointment model: You pay a standard listing fee per new patient lead, but only when a qualified patient books with you. No upfront marketing spend, no monthly subscriptions, no wasted ad dollars on clicks that don’t convert. The platform handles patient acquisition, pre-qualification, and infrastructure—you focus on clinical care.

How Klarity Health Streamlines Anxiety Treatment for Providers

Instead of spending $3,000-5,000/month on marketing with uncertain results, joining a telehealth platform removes patient acquisition risk entirely.

What Klarity offers anxiety prescribers:

Pre-Qualified Patient Flow

• Patients already matched to your specialty and availability
• Both insurance and cash-pay patient mix
• No cold leads, reduced no-show rates vs DIY marketing
• You control your schedule—only pay when you see patients

Zero Marketing Burden

• No SEO waiting period (6-12 months)
• No PPC budget testing and optimization
• No directory subscription fees piling up
• No staff time handling and qualifying leads

Built-In Infrastructure

• Integrated telehealth platform (no separate software costs)
• Billing support (platforms typically handle claims)
• Compliance framework for multi-state practice
• State-specific regulatory navigation

Economic Model

• Pay-per-appointment vs upfront marketing gambling
• Predictable cost per patient vs variable ad spend
• Immediate patient access vs months building pipeline

Multi-State Opportunities

• Reach underserved areas (Texas psychiatrist ratio: 1:8,966; Florida: 1:8,577)
• Leverage IMLC or state-specific telehealth registrations
• Platform handles state-by-state compliance nuances

For PMHNPs in restricted states, platforms can facilitate required physician collaborations, making practice viable where solo telehealth would be legally complicated.

Practical Considerations for Anxiety Prescribing via Telehealth

PDMP Compliance

Every state requires checking the Prescription Drug Monitoring Program before prescribing controlled substances:

• Florida: E-FORCSE (mandatory check)
• Texas: PMP Aware (mandatory check)
• California: CURES (mandatory check)
• New York: iSTOP (strictest—requires check for every controlled prescription)
• Pennsylvania: ABC-MAP
• Illinois: Illinois PMP (check before initiating, then every 90 days)

Document PDMP checks in your clinical notes.

Documentation Standards

Telehealth visits are audited similarly to in-person. Document:

• Patient consent for telehealth
• Clinical rationale for medication choices
• Review of symptoms, efficacy, side effects
• Treatment plan adjustments
• PDMP check confirmation

Since 2021, E/M coding is based on time or medical decision-making. A straightforward 15-minute refill is 99213; complex cases with multiple medication adjustments may justify 99214.

Controlled Substance Prescribing Best Practices

For benzodiazepines in anxiety treatment:

• Assess for substance use history
• Discuss risks, benefits, alternatives
• Set clear treatment duration expectations
• Monitor for tolerance, dependence
• Consider tapering plans upfront
• Document clinical necessity thoroughly

The DEA’s upcoming permanent rules (expected late 2026) may introduce additional safeguards. Current practice: follow standard psychiatric prescribing guidelines adapted for virtual visits.

Patient Safety in Virtual Settings

Without in-person observation, enhance assessment through:

• Video observation of affect, anxiety presentation
• Structured symptom scales (GAD-7, PDSS)
• Collateral information when appropriate
• Clear safety planning for severe anxiety/panic
• Emergency protocols if patient decompensates

Frequently Asked Questions

Can psychiatrists prescribe benzodiazepines via telehealth?

Yes. As of February 2026, federal flexibilities (extended through December 2026) permit prescribing Schedule IV benzodiazepines via telehealth without prior in-person visits. State PDMP checks are mandatory.

Do PMHNPs have the same prescribing authority as psychiatrists for anxiety medications?

It depends on your state. In Full Practice Authority states (New York, Oregon, Washington, Arizona, etc.), PMHNPs can prescribe anxiety medications including controlled substances independently. In restricted states (Texas, Pennsylvania, Florida), you need physician collaboration agreements and may face additional limitations on controlled substance prescribing.

Can I prescribe anxiety medications to patients in states where I’m not licensed?

No. You must hold an active medical license in the state where the patient is physically located during the telehealth visit. Some states participate in the Interstate Medical Licensure Compact (IMLC) to streamline multi-state licensing.

What happens when the DEA’s temporary telehealth rules expire in December 2026?

The DEA is developing permanent telehealth prescribing regulations. These may introduce a special telemedicine registration or modified exam requirements. Stay informed through DEA announcements and professional organizations, but current indications suggest telehealth prescribing will continue in some form.

How much can I realistically earn doing telehealth anxiety medication management?

Medicare pays ~$95 for a 15-minute med check. Seeing 4 patients/hour generates $380 gross revenue. Platforms typically take 20-40% service fees, netting you $228-304/hour. Compare this to the $200-500+ patient acquisition cost and months of marketing investment in solo practice.

Do I need malpractice insurance specifically for telehealth?

Most malpractice policies now cover telehealth automatically, but verify your policy covers all states where you practice and includes controlled substance prescribing via telemedicine. Platforms often require proof of coverage.

Can I prescribe Schedule II stimulants via telehealth for comorbid ADHD in anxiety patients?

Yes federally, but state restrictions apply. Texas prohibits NPs from prescribing Schedule II outside hospital settings. Florida allows psychiatric prescribers (MD and psych NPs) to prescribe Schedule II via telehealth for psychiatric disorders. Pennsylvania requires physician co-signature within 24 hours for NP Schedule II prescriptions.

Your Next Step: Evaluating Telehealth Platforms

The psychiatrist shortage is real—Texas averages one psychiatrist per 8,966 residents, Florida one per 8,577. Anxiety disorders are among the most common mental health conditions, and demand for medication management far exceeds supply.

Telehealth removes geographic barriers, but building a solo virtual practice means:

• $3,000-5,000/month marketing spend with uncertain ROI
• 6-12 months before SEO generates patient flow
• $200-500+ true cost per acquired patient
• Managing compliance across multiple states
• Handling billing, credentialing, platform costs yourself

Platforms like Klarity flip this model: pay only when qualified patients book with you. No upfront marketing gamble, no monthly subscriptions bleeding money while you wait for SEO to work, no wasted ad spend on clicks that don’t convert.

For PMHNPs in restricted states, platforms handle the complexity of physician collaborations and state-specific compliance—making telehealth practice viable where solo practice would be legally problematic.

Ready to explore how Klarity can connect you with anxiety patients while handling patient acquisition, compliance, and infrastructure?

Visit Klarity’s provider page to learn about joining the network, or schedule a call with their provider relations team to discuss compensation models, patient volume expectations, and how they support psychiatrists and PMHNPs in building sustainable telehealth practices.

The patient demand exists. The technology works. The reimbursement is solid. The question is whether you want to spend your time marketing or treating anxiety.

References and Citations

1. HHS Press Release – ‘HHS & DEA Extend Telemedicine Flexibilities through 2026’ (January 2, 2026). U.S. Department of Health and Human Services. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. Florida Statutes §464.012 and §456.47 – Nurse Practice Act & Telehealth Prescribing Rules (2024 Statutes). Florida Legislature. https://www.flsenate.gov/laws/statutes/2024/464.012 and https://www.flsenate.gov/laws/statutes/2022/456.47

3. California Board of Registered Nursing – ‘AB 890 Implementation FAQs’ (Updated 2024). https://rn.ca.gov/practice/ab890.shtml

4. Nurse Practitioners of New York – ‘Breaking News: NP Modernization Act Passes’ (April 9, 2022). https://npny.enpnetwork.com/nurse-practitioner-news/216175-breaking-news-np-modernization-act-passes

5. Texas Medical Board FAQ – ‘Who Can Prescribe Schedule II Drugs Under Physician Delegation’ (Current as of 2026). https://www.tmb.state.tx.us/274-who-can-prescribe-schedule-ii-drugs-under-physician-delegation

Source:

• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=Nurse%20practitioners%20,three%20categories%20of%20practice%20authority
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=Illinois%20is%20one%20of%20the,that%20they%20can%20handle%20unsupervised
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,19%20pandemic%20and
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=2025
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20telemedicine%20flexibilities%20were%20first,off%20access%20to%20needed%20medications
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20extension%20gives%20DEA%20and,patient%20safety%20and%20preventing%20misuse
• https://www.flsenate.gov/laws/statutes/2022/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.littlehealthlawblog.com/texas-state-telemedicine-prescribing-rules/#:~:text=C
• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=While%20any%20NP%20with%20prescriptive,Their%20expertise%20includes
• https://npny.enpnetwork.com/nurse-practitioner-news/216175-breaking-news-np-modernization-act-passes#:~:text=On%20April%209th%2C%20Governor%20Hochul,Practice%20Authority%20for%20NYS%20NPs